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Abstract: Molecular modeling techniques provide a powerful tool to study the properties 
of molecules and their interactions at the molecular level. The use of computational 
techniques to predict interaction patterns and molecular properties can inform the design of 
drug delivery systems and therapeutic agents. Dendrimers are hyperbranched 
macromolecular structures that comprise repetitive building blocks and have defined 
architecture and functionality. Their unique structural features can be exploited to design 
novel carriers for both therapeutic and diagnostic agents. Many studies have been 
performed to iteratively optimise the properties of dendrimers in solution as well as their 
interaction with drugs, nucleic acids, proteins and lipid membranes. Key features including 
dendrimer size and surface have been revealed that can be modified to increase their 
performance as drug carriers. Computational studies have supported experimental work by 
providing valuable insights about dendrimer structure and possible molecular interactions 
at the molecular level. The progress in computational simulation techniques and models 
provides a basis to improve our ability to better predict and understand the biological 
activities and interactions of dendrimers. This review will focus on the use of molecular 
modeling tools for the study and design of dendrimers, with particular emphasis on the 
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efforts that have been made to improve the efficacy of this class of molecules in 
biomedical applications. 
Keywords: dendrimers; molecular dynamics; molecular docking; biological interactions; 
drug encapsulation; dendrimer-drug interaction; biomaterials; hyperbranched polymer 
design; molecular recognition; nanomedicine 
 
1. Introduction 
Dendrimer is a name derived from the Greek word dendros (tree or branch) and meros (part of) [1] 
to describe a class of macromolecular hyperbranched polymers with a well-defined radial branching 
architecture. Contrary to most other polymers—i.e., linear and branched polymers—dendrimers often 
do not rely on statistical description of average structure and molecular weight characteristics [2]. 
Dendrimers can be synthesised by iterative stepwise reactions of monomers. The synthetic route is 
often characterized as either divergent (from the centre outwards) or convergent (from the outside 
towards the centre) [3]. 
Of these two methods, divergent strategies appear to be better suited for large-scale production.  
The synthesis starts from the core where consecutive generations or layers, of what is often a  
tri-functional monomer are added. Moreover, often two functional groups of this monomer are masked 
(i.e., protected from reaction). Each monomer then undergoes reaction at the one available functional 
moiety leaving the two masked moieties available for repeat reaction after deprotection. Hence each 
iterative reaction sequence or generation doubles the number of end groups as the dendrimer grows 
(Figure 1A). This method, however, has some drawbacks since incomplete or side reactions results in 
structural heterogeneity, especially as the number of generations increases. This is often thought to be 
due to increased steric interactions as the number of end groups increase. There are, however, 
purification challenges (see [4,5]) with this strategy, when trying to separate dendrimers that differ by 
small differences in monomer incorporation. To overcome these hurdles, at small scale, convergent 
methods of synthesis were developed [6]. In these methods the structure is built from the ends of the 
branches towards the dendrimer core. The monomers undergo reactions to form the arms that are then 
covalently linked to the core (Figure 1B). Convergent methods, though solving the purification and 
side reaction problems of the divergent methods do not allow the synthesis of high generation 
dendrimers due to steric effects that are encountered when trying to bring the dendrimer fragments 
(called dendrons) together to react with a reagent that forms the core [5]. 
Generally, dendrimer structure can be described by the: (i) core; (ii) branches; (iii) terminal groups 
and (iv) void space. Due to the iterative chemistry underlying dendrimer synthesis, these macromolecules 
are usually described by their generation number, for example generation 0 (G0), 1 (G1), 2 (G2) and so 
on. It is also common to describe the dendrimers as half-generation when the terminal groups of the 
last monomer are altered (e.g., G1.5 or G1.5-COOH) to change chemical functionality of the end groups. 
Molecules 2014, 19 20426 
 
 
Figure 1. Structural properties of dendrimers; (A) Divergent synthesis; (B) Convergent 
synthesis; (C) Different topological structures that can be obtained from synthesis.  
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As with all molecules, dendrimer structure correlates with properties and applications. There are 
key intrinsic features that include the potential for the precise control of molecular weight, branching 
and interior chemistry. Interestingly, since dendrimers are hyperbranched they tend to have much 
lower viscosity properties compared to linear polymers of comparable molecular weight. For some 
dendrimers, the intrinsic viscosity reaches a maximum with the increase in molecular weight and then 
decreases with further increase of molecular weight (see [7,8]). Synthetic versatility can usually be 
achieved to give multivalent terminal groups and a wide variety of cores (see [9,10] and as reviewed 
elsewhere [1,11–13]). A vast array of dendrimer structures have been prepared since dendrimers were 
first described [14] and the potential number of structures of these molecules is almost limitless 
(Figure 1C).  
In principle, dendrimers can be composed of any type of monomer and hence different physicochemical 
behaviours can be expected based on the kind of monomers used. A widely described example is the 
poly(amidoamine) (PAMAM) dendrimers. These are the most extensively studied dendrimers in the 
biomedical field. Other commonly studied dendrimers include poly(propylene imine) (PPI or DAB) [15], 
polypeptides [16], poly(ester) [17], triazines [18] and phosphorus-containing [19] dendrimers. The 
final end groups can be further modified with other chemical moieties including recognition moieties 
(e.g., folate, glutathione, RGD, immunoglobulins (Ig)), lipids and bioresponsive elements or polymers 
(e.g., PEG (polyethyleneglycol)) to optimise the biological properties [20–22]. 
Dendrimers can also act as materials, excipients or active molecules and can be applied as catalysts, 
in the preparation of hydrogels, biosensors (molecular recognition), tissue engineering, drug delivery 
systems, transfection agents and even as therapeutic agents or biomimetics. Hence the recurrent need is 
to develop a better understanding to aid the design and increase the performance of these 
macromolecules (for further reading see [23–30]). 
Computer simulation techniques are a valuable tool to predict the properties of dendrimers at the 
molecular level. By gaining insight into the key biomedical factors that correlate with dendrimer 
structure one can design and optimize their properties for various applications. Nevertheless there is 
still a great challenge to develop novel dendrimers as any modification (e.g., terminal groups) in the 
dendrimer structure is likely to alter its morphological properties and hence its biological activity and 
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toxicity (reviewed elsewhere [31–33]). Therefore a better understanding how these macromolecules 
interact with the biological systems is required to develop safer therapeutics.  
Although the use of molecular modeling techniques for dendrimers can be a powerful tool, there is 
a lack of dedicated software for these macromolecules. In particular, force field development still 
presents a significant challenge to model dendrimer properties. Herein we review the current strategies 
used to computationally model dendrimers and describe how these models have been applied to 
develop dendrimers for use in drug delivery and as therapeutic agents. 
2. Molecular Modeling of Dendrimers 
Several parameters impact on the architecture of dendrimers in aqueous medium. These include 
generation number (size), type of monomer (e.g., spacer length, density groups, void space and 
branching units) and surface terminal groups (charge and hydrophobicity) (see Figure 2). Valence of 
counter-ions in the solution and presence of other molecules, pH or ion salt concentration, also play  
a role. Several experimental techniques are used to probe dendrimer structure, including nuclear 
magnetic resonance (NMR), mass spectroscopy, infrared and Raman spectroscopy, fluorescence and 
small angle neutron scattering (SANS) (as reviewed in [34]). Although these techniques provide 
valuable information about the size and molecular constituents they have some limitations. For example, 
the determination of spatial configuration and geometric characterization [35] can be challenging. 
Since dendrimers are essentially a repetitive sequence of monomers, probing configurations is limited 
due to the low differentiation of the signal. Furthermore, flexible dendrimers can have a number of 
permissible configurations in solution with a rapid interchange between them [35–38]. Nevertheless, 
sometimes, specific chemical groups can be used to probe their local environment if they are different 
enough. As an example, amide protons in a poly(L-glutamic acid) dendrimers had separate NMR 
chemical shifts and those were used to probe their exposure to solvent in two different generations by 
changing the temperature [39], as well as to obtain information about flexibility and the association of 
lipidic peptide G3 dendrons [40].  
Computational techniques can offer valuable insight into the study and exploration of the properties 
of complex systems such as dendrimers. Properties such as conformational analysis, molecular 
interaction (biological and drugs) and validation of experimental data can be determined by molecular 
modeling strategies. Ultimately, molecular modeling strategies have the potential to provide valuable 
data, which can help to minimize often laborious and expensive laboratory experiments. We believe 
that experimentation can be made much more efficient when guided by rational design. 
Using only theoretical models or even experimental data, simulations can render mechanisms of 
biological interactions at atomic-level resolution. From the initial theoretical models to complex molecular 
simulations [41] there has been a great investment in understanding how these macromolecules  
behave (Section 3). A major benefit from molecular modeling is that allows the user to control  
every key parameter (e.g., ions, pH, dendrimers’ structure) that might be involved in their biological 
activity [42–45]. This comprises simulations in conditions that would be too difficult to study 
experimentally. Examples of such value could be the study of dendrimers with lack of one dendron or 
defective parts of the branches. This opens a promising avenue for interpretation and validation of 
experimental data [46] as well as the design and characterization of many biological interactions. 
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Figure 2. Topological structures obtained with different core and branching monomers; 
From top to bottom: monomeric units, 2D structure of a G2 dendrimer, 3D structure of  
G2 dendrimer.  
 
Understanding molecular interactions is fundamental to improve biological activity. Based on the 
energy potential function, molecular dynamic simulations of dendrimers have focused on their behaviour 
in aqueous solutions (Section 3.1) as well as in interacting with drugs (Section 3.4) and biomolecules 
including lipid membranes (Section 3.3), nucleic acids and proteins [47–53] (see Figure 3 and Section 3). 
Moreover, dendrimers can be seen as protein-like, a sequence of monomers in a three dimensional 
assembly. Therefore not only their structure can be generated in similar fashion as proteins but 
modeling techniques such as molecular docking studies can be applied [38,54]. Docking studies allow 
greater insight on interaction of dendrimers with drugs and biological target. In this regard, docking of 
several hydrophobic molecules (resveratrol, curcumin and genistein) was able to show that the 
interaction was mainly in the hydrophobic parts of the dendrimer with some hydrophilic interaction via 
the hydroxyl groups [55]. Docking studies also contribute to improve dendrimer design, allowing the 
selection of potential groups that will increase affinity [56,57]. In a recent study, PAMAM dendrimers 
partially glycosylated were found to dock with MD-2 protein in such a way that was able to prevent its 
interaction with LPS (Lipopolysaccharide) [52]. 
The crucial step when using molecular simulations techniques is to establish the main questions and 
goals for the intended study. With current access to computational power it is possible to perform more 
and more complex simulations, despite the yet great challenge to accurately describe complex systems, 
in a reasonable time scale [58]. The prediction of dendrimer properties can be studied under different 
ensemble configurations (temperature, pressure and volume), which can sometimes be challenging due 
to the high molecular density and conformations that need to be defined. Depending on the time-scale 
and properties to be evaluated, there is no single method available that will provide all the different 
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types of information desired. Dendrimers can be simulated alone or in a certain concentration in the 
solvent, in the presence of small drugs, proteins and nucleic acids or even in the presence of a lipid 
bilayer. These involve different scales of the number of atoms necessary to simulate and hence the 
computational cost differs. Ideally, these simulations would be carried with all atoms taken into 
account (all-atom simulations) to get a finer description of the interactions involved (e.g., hydrogen 
bonds). However, due to the resources available and the time scale necessary to study certain events 
(e.g., incorporation of a drug inside the dendrimer), it is sometimes required the use of simplified 
models. In this regard, coarse-grained simulations have been a valuable tool in particular to study the 
interactions with lipid bilayers [53,59–61]. 
Figure 3. Biomedical applications where MD has been important to probe biological interactions.  
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2.1. 3D Structure Generation 
To provide a more general modeling procedure to study dendrimers there is a need for an 
appropriate nomenclature capable of accurately describing their topology and structure. To start with, 
the naming and description of the 2D structure (topology) of these molecules is still not universally 
accepted. IUPAC nomenclature is generally an acceptable way of naming molecules and should enable 
the exact description of any type of a molecule. Though this nomenclature can be applied to 
dendrimer-like molecules, it becomes less clear with the increase of dendrimers’ size and does not 
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capture all the necessary structural features (e.g., distribution of residues). Nodal nomenclature based 
on graph theory is also able to describe dendrimers but has not been widely used [62,63].  
Other two nomenclatures for dendrimeric structures are the Newkome-nomenclature [64] and 
cascadane [65]. Both of these nomenclatures are capable of representing the hyper-branched nature of 
dendrimers. Both systems make use of the repetitive units that constitute dendrimers to simplify their 
notation [64,65]. However, as the dendrimers increase in size, the notation becomes complex and difficult 
to interpret. Further simplification on dendrimer nomenclature, taking advantage of their repetitive 
topology and symmetry has been proposed with a dotted cap notation [63]. This notation represents 
dendrimers as building blocks, with a core unit, monomers and capping groups. The core is bound to 
the monomers which forms the dendrimer framework where the caps are attached [63]. The dotted cap 
notation then represents the surface of the dendrimer by means of sequential caps (Figure 4). Figure 4 
shows an example of how the dotted cap notation would be used to interpret a poly(lysine) dendrimer.  
Figure 4. Example of the dotted cap notation for a poly(aspartic acid) dendrimer; The 
dendrimer is represented by the core, branches and capping groups; This type of notation is 
useful since several capping groups with different branching points can be easily compared.  
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In this case the final notation would be WZ●●WZ●●●WZ●●WZ●●●WZ●●WZ●●●WZ●●WZ or 
(WZ)8 in condensed notation [63]. Here the ● represents the topology distance between the capping 
groups from the primary atom represented in the core. However, as seen in the example, no information 
regarding the core or branching units is given, restricting the value of this nomenclature to comparison 
purposes between complex structures, with variable surface topology. Despite the importance of 
nomenclature and its contribution to the description of dendrimer topology, it does not provide information 
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on the 3D structure arrangement. Different strategies had to be developed to quickly and effectively 
generate 3D structures and describe topology. In principle, any chemical drawing software should be 
sufficient to construct a representation of the dendrimer. Unfortunately the manual assembly of these 
macromolecules is tedious and highly prone to mistakes, especially with higher generation dendrimers.  
To ease this task there are four main packages dedicated to sequential assembly of molecules namely 
Gromacs [66] and XPLOR [67,68], Starmaker (part of Silico) [69] and Dendrimer Building Toolkit 
(utilizing AMBERTOOLS) [70]. The first has primarily been used for the dynamic simulation of proteins. 
XPLOR is used for structure generation based on NMR and X-ray experimental data while the last  
two packages are dedicated to dendrimer assembly. Regardless of the software package, the topology 
and parameters of initial monomers have to be defined for the force field that is to be used. All of the 
information regarding each individual atom and how they are brought together first in monomers and 
further along as a molecule then needs to be described. It is important to note that the topology and 
parameter files are specific to each force field. These files often limit the ability to inter-convert between 
these four molecular assembly packages. 
Figure 5. Strategy employed for building dendrimers of different types and generations 
using XPLOR [71].  
Topology file
MASS NH  14,007
MASS CA  12,01
:
RESIdue LYS
ATOM NH TYPE N1  CHARGE -0,71 END!
ATOM CA TYPE C1  CHARGE  0.04 END!
:
BOND
BOND N1 C1 
:
PATCH CONNECT_LYSINES
DELETE 1HN END!
BOND 2OC 1NH END!
:
Parameter file
BOND 
BOND N1 C1 454 1,492 !
BOND OC NH 744 1,382 !
:
ANGLE
:
DIHEDRAL
:
NON BONDED
:
Describe dendrimer as a sequence
Core
LYS 1
Branch 1
LYS 2
Branch 2
LYS 3
1st Generation
Patch 1
Patch 2
Core
LYS 1
Branch 1
LYS 2
Branch 2
LYS 3
Patch 1
Patch 2
Branch 1
LYS 4
Branch 2
LYS 5
Branch 3
LYS 6
Branch 4
LYS 7
2nd Generation
Patch 1
Patch 2
Patch 1
Patch 2
Core
LY1
Branch 1
Branch 2
Core
LY1
Branch 1
LYS 2
Branch 2
LYS 3
Branch 1
LYS 4
Branch 2
LYS 5
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LYS 6
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Recently, a protocol has been described that facilitates dendrimer construction by describing the 
dendrimer and the connection between monomers in a sequence [71] using the XPLOR-NIH program 
(see Figure 5). This requires that the monomers are constructed in the initial stages, which can be 
achieved by common programs for molecular drawing. These monomers have to be defined within 
both the topology and parameter files in the XPLOR format. All the information regarding each 
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individual atom and how they are brought together first in monomers and further along as a bigger 
molecule is described for use in standard molecular dynamics methods. The software then takes the 
sequence and its connectivity, and assembles each monomer through a simulated annealing protocol so 
that it can minimize clashes in the structure.  
2.2. Simulation of Dendrimers 
After obtaining the Cartesian (x, y, z) or internal coordinates of either the whole dendrimer or the 
monomers, the structures are then minimized. Since dendrimers have a large number of atoms, 
establishing the initial conditions to perform the simulations is a laborious task due to steric overlaps 
and biased local minima. Moreover, appropriate stereochemistry should be checked as this can lead to 
erroneous initial structures that are not corrected during the simulation.  
Currently there are various approaches to perform molecular simulations. They are based on 
quantum and molecular mechanics and molecular dynamics. However, in the case of dendrimers, 
molecular mechanics and dynamics are mostly used due to the high computational cost of quantum 
calculations. The quantum mechanics or ab-initio approach is limited to the lowest generation 
dendrimers or to defined monomers in an initial conformation. To overcome issues with the size of 
dendrimers, strategies similar to those used for modeling of proteins such as molecular mechanics 
methods with reliable parameterization, semi-empirical methods and hybrid quantum/molecular 
mechanics may give reliable results [50]. 
The force field (FF) establishes the forces that will be applied to simulate the behaviour of atoms 
within the dendrimer structure as a function of time [42]. The force fields represent the potential 
energy and define the forces applied to the system (ensemble of N atoms), which includes the sum of 
bonded (bond-length, bond-angle, torsion terms) and non-bonded (electrostatic and van der Waals 
interactions). Commonly force fields that have been used for dendrimers include the AMBER [43,72], 
CHARMM [73–75], GROMOS [38,76], MARTINI [77–79] CVFF [80,81], OPLS [29,82,83] and 
DREIDING Force [84,85]. An overview of the different force fields applied to dendrimers can be seen 
in Table 1. Force fields use different methods for parameterization and can refer to general atom types 
or to specific classes of molecules. It is, therefore, extremely important to make sure that the parameters 
are suitable for the system, when choosing the FF to use, as its choice can lead to different outcomes.  
All-atom simulations were conducted with PAMAM dendrimers from G2 to G6 using different force 
fields (DREIDING, COMPASS and CVFF) and coarse-grained models using the MARTINI [79].  
To compare the performance of each FF the radius of gyration (Rg) was measured and compared to 
experimental values of SAXS (small angles X-ray scattering) [86]. All Rg values for the different  
all-atom FF were lower when compared to the Rg values determined by SAXS. Similar values were 
obtained for COMPASS and CVFF force fields with closer values to the experimental results. 
DREIDING FF was the least reliable for smaller size dendrimers (G2–G4) and similar to the others 
for higher generations (G5 and G6). However, the scaling of size in the case of DREIDING FF was 
found to be similar to previous Brownian dynamic simulations (Rg ~ N1/3) and the fractal dimensions 
(space occupied) were similar to those determined experimentally. For these reasons the authors 
concluded that DREIDING was the best for determining the Rg for PAMAM dendrimers. 
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Table 1. Examples of software used to build and simulate different types of dendrimers; * NA: the software was not disclosed; § Free use; ƚ Commercial use. 
Dendrimer Type 
Software for 
Dendrimer Construct 
Software Used for 
Simulations 
Force Field Aim of the Study 
Conformational analysis 
PAMAM G2 to G6 [87] Insight II 
Insight II ƚ CHARMM 
ƚ 
CVFF CHARMM 
Structural features at different pH  
and generations 
PAMAM G5 [88] NA* MPsim DREIDING 
Effect of pH to study the water dynamics  
on dendrimers 
PAMAM G50% and 90% acetylated [89] Insight II AMBER8 ƚ GAFF Effect of acetylation on structural features 
Glycosylated PAMAM G3.5 [90] XPLOR Desmond § OPLS_2005 Effect of glycosylation on structural features 
Triazine G3 and G5 with DOTA terminals [91] AMBER 11 AMBER 11 ƚ GAFF and parm99 
Location of DOTA groups complexed  
with Gd ions 
PEgylated PAMAM G3 to G5 [92] NA * GROMACS § MARTINI 
Effect of PEGylation on the structure  
and interparticle interaction 
Pegylated triazine dendrimers linked with paclitaxel [72] Material Studio 5 AMBER 11 ƚ parm99 
Effect of PEGylation on availability  
of linkers 
Carboxylic modified PAMAM G5 with gold, 
fluorescein isothiocyanate (FI) and folic acid (FA) [93] 
Insight II Insight II ƚ CVFF Conformation and location of FI and FA 
PAMAM G5 with amine, carboxyl and acetamide 
groups linked to fluorescein and folic acid [80] 
Insight II Insight II ƚ CVFF Location of folic acid and its availability 
PAMAM G5 with methotrexate [29] CHARMM  CHARMM ƚ CHARMM  
Location of MTX when directly linked  
or with a spacer 
Poly(L-lysine) and Poly(amide) G4 dendrimers [94] Starmaker (Silico) NAMD § OPLS-AA 
Comparison of dendrimer architectures  
in solution 
Dendrimer-small molecule interactions 
PAMAM G5 with different terminal  
groups + methoxyestradiol [81] 
Insight II  Insight II ƚ CVFF 
Influence of terminal groups  
on the complexation 
PAMAM G4 + polyphenols [55] ChemOffice Ultra 6.0 HyperChem Pro 7.0 ƚ MM+ Free binding energies 
PAMAM G3 + nicotinic acid, nicotinate and  
3-pyridiniumcarboxylate [95] 
HyperChem NAMD § CHARMM27 
Free energy of binding and the effect  
of pH variation on binding 
Peptide dendrimers + hydroxypyrene trisulfonate 
butyrate ester [38] 
CORINA GROMACS § GROMOS-96 43a1 Conformation and docking site location 
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Table 1. Cont. 
Dendrimer Type 
Software for 
Dendrimer Construct 
Software Used for 
Simulations 
Force Field Aim of the Study 
PAMAM G5-Folic acid + Morphine and Tramadol [96] ICM NAMD § 
CHARMM 27; 
ParamChem 
Different pHs; Binding mechanism 
elucidadtion; Location of folic acid 
PAMAM G5 + salicylic acid, L-alanine, 
phenylbutazone, primidone [97] 
DBT/AMBER AMBER9 ƚ GAFF 
Effect of pH on interaction and  
relation with drug release 
Poly(L-lysine) G4 dendrimer + doxorubicin [83] ChemBioOffice Desmond § OPLS-AA Complex formation 
Dendrimer-nucleic acid interaction 
Triazine G2dendrimers + siRNA or DNA [98] AMBER 10 AMBER 10 ƚ Parm99 
Binding mechanism and  
energy contributions 
PAMAM ssDNA [49] AMBER 7 AMBER 7 ƚ 
AMBER 95 (DNA) 
DREIDING (dendrimer) 
Binding interaction and  
energy contributions 
PAMAM G3 DNA [75] NA * NAMD § CHARMM 27 Complexation mechanism 
PAMAM G0 and G1 + siRNA [43] Material Studio 5 AMBER9 ƚ 
Ff99 FF for RNA GAFF 
for dendrimers 
Effects of pH on the complexation 
PAMAM G7 + siRNA [99] Material Studio 5 AMBER10 ƚ 
GAFF (non-standard 
residues); parm99  
Complex interaction 
Dendrimer-protein interaction 
Glycosylated PAMAM G3.5 + MD-2 protein [52] XPLOR Desmond § OPLS_2005 
Docking and interaction between active  
and non-active forms 
PAMAM G4 Albumin [47] NA * NA * DREIDING  
Contact points between dendrimer-albumin 
at physiological pH 
PAMAM G0 with guanidinium terminal groups  
α-chymotrypsinogen A [73] NA * NAMD 
§ CHARMM 27 
Site of interaction with the protein  
and effect of salt types 
Dendrimer-lipid bilayer interaction 
Acetylated and non-acetylated PAMAM G5 and  
G7 + DMPC [53] 
Insight II GROMACS § 
MARTINI and  
adapted MARTINI 
Effect of size, charge and concentration on 
dendrimer-membrane interaction 
PAMAM G3 and G5 with different acetylation  
levels + DPPC [60] 
Insight II GROMACS § MARTINI 
Effect of size, charge and lipid phase on 
dendrimer-membrane interaction 
PAMAM G3 with amine, acetyl and carboxyl 
terminals + DMPC [74] 
CHARMM CHARMM ƚ 
CHARMM27 (lipid) and 
CHARMM 22 (dendrimer) 
Effect of terminal groups and lipid phase 
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The usefulness of DREIDING FF to predict the behavior of a PAMAM G4 dendrimer in solution 
was recently reported. This was the first report of a FF to be able to describe that the radius of gyration 
was independent from the pH and instead a reorganization of the internal structure occurs [85] (see 
Section 3 for more details). When compared to coarse-grain (CG) simulations, the Rg was found to be 
similar to those obtained by DREIDING FF. These studies confirmed the usefulness of the CG model 
when systems with larger length scales are simulated. 
Finally, the surrounding environment should be defined as precisely as possible. This includes the 
presence of water molecules or other solvent, ions, lipid membranes or other molecules such as drugs. 
Although the dendrimer can be simulated in vacuum, this is not ideal due to the effects of solvent 
polarization on the structure. In the absence of explicit solvents and counter-ions, special care has to  
be taken since such approximations may lead to non-physiological conformations of the dendrimer. 
PAMAM G2 dendrimers were tested with different parameters to describe the implicit use of solvent 
and compare to the use of explicit solvent. It was observed that modifying the non-bonded cut-off 
distance and dielectric constant could led to radius of gyration different from those find with explicit 
solvent [87]. 
In simulation experiments, solvent molecules can be either modelled explicitly or implicitly. 
Explicit solvent calculations account for each individual water molecule, which is computationally 
demanding. Implicit simulations translate the behaviour of water into the forces experienced by the 
dendrimer. Although this introduces a simplification in the simulation, studies using both explicit and 
implicit solvents have shown good agreement [87,100]. 
Another way to simulate the solvent is through an intermediate approximation of a hybrid 
implicit/explicit solvation model. This approach uses explicit solvent only in the layer closer to the 
dendrimer ([35,101] for more information). This kind of approach was used to study the structural 
conformation of dendrimers in different solvents being able to reduce the computational costs and 
having an accurate solvation in the dendrimer interface [35]. After setting the parameters, the actual 
simulation is allowed to run. Several methods have been used but the majority of simulations 
performed on dendrimers have been (i) Brownian Dynamics (BD), (ii) Monte Carlo (MC) or (iii) 
molecular dynamics (MD).  
BD uses simplifications that allow longer time-scale calculations. In these simulations individual 
dendrimers are treated as Brownian particles and evaluated for friction in the surrounding solvent  
(the flow) (reviewed [102]). This model was used to study the polyelectrolyte complexation between  
a charged G3 and G4 dendrimers and a linear polymer with the opposite charge. From these 
simulations it was observed that the polymer chain was adsorbed to the dendrimer in a higher amount 
than that required to neutralize the dendrimer [103]. 
MD and MC models are used to study the performance of dendrimers in biological systems 
including structural configuration and thermodynamic calculations. In general, dendrimers are defined 
with a starting configuration and then by assuming ergodic conditions, the system is minimized 
towards a low free energy. In this process, MC simulations use iterative random atomic displacements 
of the initial configuration to generate a new energy value which is then accepted or rejected by 
association of a probability function using Boltzmann statistics. This will depend on whether the study 
is performed in NVT (number of particles, volume and temperature constant) or NPT (number of 
particles, pressure and temperature constant) ensemble. The system is therefore evaluated to find a 
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minimum configuration potential energy. By setting up constrains, the number of degrees of freedom 
can be reduced to decrease the computational demand. For this reason, allowing only important 
rotatable bonds to change is usually a good approximation.  
Significant improvements for dendrimer analysis have been performed by MC parameterization 
using Continuous Configuration Boltzmann Biased direct Monte Carlo (CCBB MC) [35]. With MC, 
the dendritic chains torsional angles are sampled in a step-by-step process [35], conversely with CCBB 
MC they are sampled using a weighting function ([104]). These types of simulation, however, do not 
provide dynamic information. Dendrimers can be highly flexible and therefore the number of sampling 
conformations can be very high. In order to acquire information about dendrimer dynamics, which is 
very relevant in a biological environment, molecular dynamics should be used. 
Molecular dynamics decrease computed simulation time (compared to QM) by introducing 
simplifications that assume that molecules interact as particles via classical mechanics of motion.  
In MD simulations, atoms interact over time by addition of impositions (temperature, pressure, time), 
restrictions (neglect of quantum mechanics and relativistic effects) and the integration of equations  
of classical mechanics (Newton mechanics, which represents the motion of the system). This allows 
following the trajectory of atoms with a high spatial resolution. 
Before performing the actual measurement, energy minimization is advised. This can be achieved 
with a short simulation with restrictions to the degrees of freedom. For example, in the case of  
a peptide bond, these can be restrained to maintain planarity. At this point it is necessary to be careful 
so that the initial structure does not end in a local minimum, which can be difficult to reverse.  
An interesting approach to circumvent this was proposed by changing the partial charge to +0.1e of all 
atoms followed by an increase in temperature to 500 K. This promotes the extension of the structure to 
be evaluated [105]. Another approach that can guarantee that the dendrimer branches are the farthest 
away from each other can be the addition of NOE constraints during the assembly of monomers using 
XPLOR [71]. 
After minimisation, the equations of motion are used in iterative time-steps to simulate the 
dendrimer and the surrounding system of desirable conditions. Depending on the simplification of the 
model (e.g., all-atom simulation, coarse grained) different information can be obtained from the 
simulations. All-atom simulations can be performed with dendrimers but might require high 
computational resources. This type of simulation gives relevant information including the 3D 
configuration and atomistic detailed interaction events.  
Coarse-grained simulations can offer greater simplification allowing the system size and the 
simulation time-scale to be increased while still providing significant realistic details [42]. This can be 
accomplished by a reduction in the number of degrees of freedom. By defining an “atom” that 
represents an average of n atoms (generally four non-hydrogen atoms) the simulation demand is 
decreased. This allows a broader range of simulations to be performed, but at a cost of losing an 
accurate reproduction of structural details (lower resolution). For example coarse-grained simulations 
do not provide information about hydrogen bonding [42]. Nonetheless, this method is still used as a 
valuable tool since it has shown to be valid for large systems including lipids and dendrimers  
(Section 3.3). As a result of reducing the number of particles and the number of degrees of freedom, 
the time-step can be greatly increased.  
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After performing a simulation, there are particular features that can be obtained and analysed.  
These include the radial distribution function (RDFs), solvent accessible surface area (SASA)  
and solvent excluded volume (SEV), radius of gyration (Rg), shape descriptors, counting number of 
hydrogen pairs, and the mechanistic interactions as well as the thermodynamic parameters associated 
with them. Together these features can provide a profile of a given dendrimer.  
RDFs are especially interesting to evaluate dendrimers as drug delivery systems since they provide 
additional insight into the distribution of all the constituents of the system. A peak in this kind of 
representation indicates the distance from the centre of mass (for example) at which atoms remain in  
a locked conformation for a long time. In contrast a diffuse distribution can either mean a 
homogeneous distribution throughout the area of interest or a molecular movement. RDF can therefore 
be used to study the distribution of atoms such as water molecules, ions and drugs within the 
dendrimers’ interior. For example, the distribution of Mefenamic acid in PAMAM G2 and G3 revealed 
that both dendrimers were able to encapsulate it through internal and external interactions giving an 
estimate of the number of molecules involved in these interactions [106]. It also measures the terminal 
group distribution which can be highly valuable to study the exposure of specific groups with targeting 
functions [72]. In this regard, the effect of surface groups was studied on the radial distance of folic 
acid from the center of mass. This study showed that depending on the dendrimers’ surface group, the 
folic acid would be more or less exposed to the surface [80]. This can also be used to define the 
hydrodynamic radii of the solvated dendrimer by analyzing the solvent around [38].  
SASA and SEV also give valuable information about dendrimer structure. These parameters allow 
the determination of geometrical shape, available non-solvent accessible internal space and the 
accessibility of groups of interest to the solvent (solvent accessible volume). As an example, if the 
release of a moiety is sensitive to the solvent, this information can be used to design dendrimers that 
can effectively burry or expose this molecule. Such case was studied by MD for the availability of 
labile linkers on different PEGylated dendrimers, to see if the linker was available, and could therefore 
act as a prodrug [72]. SASA and SEV examine the molecular surface with a spherical solvent probe to 
roll around the van der Waals spheres of the macromolecule. This modeling strategy can also provide 
information related to the internal cavities [107] and can be used to estimate how many molecules the 
dendrimer will be able to carry. This is particularly useful to characterize different types of dendrimers 
and compare which one has the highest potential. This strategy was applied to two families of 
denamide and denurea dendrimers where the measurement of the internal cavity size and volume was 
used to estimate the theoretical number of molecules that would fit into these cavities [107].  
Finally, the Rg, which is correlated to the size, allows the comparison of simulation data with the 
experimental data and therefore the validation of the simulation model. When simulation values are 
similar to the experimental ones, it is expected that the simulation forces are well described. The 
analysis of Rg values can provide insight into the swelling or shrinkage of the dendrimer in the 
different conditions [85]. In particular several simulations have been performed on PAMAM dendrimers 
at different pH and salt concentrations to understand its behaviour in solution (see Section 3.1). The 
radius of gyration can also be calculated from the gyration tensor to provide insight into the shape of 
the dendrimer. In this case, several ratios between the various components of the gyration radius (in 
the x y z direction) can inform on whether the dendrimers is shaped like a sphere or more as an 
ellipsoid [105].  
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2.3. Molecular Docking of Dendrimers 
Before performing the actual docking of drugs into the structure, it is possible to estimate the 
potential of the dendrimer architecture to accommodate the drug inside. To illustrate this, two types of 
dendrimers (oxy-urea and oxy-amide groups) with varying branch lengths were evaluated for their 
cavity sizes that were available for host interaction with anti-parasitic drugs [107]. Equilibrated 
dendrimers were obtained from MD and the cavity dimensions in the interior were estimated from the 
difference between the van der Waals volumes and the solvent-excluded volumes. Since the size of the 
probe can over-estimate the molecular dimensions, an adequate probe size was first determined on the 
slight inflexion of the SASA curve vs. sphere radius. Measurements of cavity size were shown to be 
dependent on the increase of the generation but not significantly for branches derived from aliphatic 
chains. Also, oxy-urea dendrimers were less porous than oxy-amide, seemingly due to intramolecular 
interactions [107]. The oxy-amide dendrimer was found to be more adequate for the incorporation of 
molecules since it was more flexible and had more adequate size of cavities.  
The measure of the cavity size can also be used to quickly estimate the maximum number of drug 
molecules that can be incorporated into the dendrimer [54]. However, these do not account for the 
favorable or unfavorable interaction energies that may occur between the dendrimer and candidate 
drugs. For this reason docking scores can be used to calculate free energies of individual binding sites. 
Modified PAMAM dendrimers were blindly docked with curcumin in Autodock using a grid box with 
0.3750 Å spacing. Experimentally it was found that this dendrimer could accept up to 5 molecules  
and thus the most favorable energies calculated by the docking score (in the range of 4.04 and  
−7.28 kJ·mol−1) were attributed to be the binding locations [108].  
The alternative approach can also be used in which the docking conformations are first prepared to 
give the starting point structure for MD simulations. In this case the drugs can be placed in the interior 
of the dendrimer instead of randomly placed near the dendrimer with the hope that the drug will find 
the docking site along a trajectory in a short period of time. This is difficult to accomplish for large 
systems given the density of monomers on the interior. However this approach can prevent the 
possible clashing of atoms, which can occur when attempting to manually introduce the drug into 
voids of the dendrimer.  
Using this random approach, four different drugs (salicylic acid, L-alanine, phenylbutazone and 
primidone) were docked to the interior of a PAMAM G5 where the grid box was limited to the center 
region in AutoDock Vina [97]. The best docking score conformations for each drug were then used as 
initial structure for further MD simulations with AMBER with explicit water as solvent. Another 
interesting way that has been reported to incorporate drugs into dendrimers is to artificially create 
cavities inside the dendrimer. This can be accomplished by applying a force to a select number of 
atoms and then inserting the drugs into those cavities with common docking software such as 
AutoDock [109]. 
Dendrimers can also be treated as the ligand instead and the receptor can be a protein. The protein 
model of A2A receptor homodimer linked to an agonist (CGS21680 molecule) was used as reference 
to study if multiple copies of this agonist linked to a PAMAM G3 would be able to simultaneously 
occupy both subunits of the receptor. To create this kind of docked molecule, a small part of the 
dendrimer was first docked into the protein and then the rest of the dendrimer was attached with the 
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favorable docked agonists already in place (see Figure 6). This created some clashes of overlapping 
branches with the protein which were then manually adjusted followed by minimization and 
subsequent MD simulation [48].  
Figure 6. Docking strategies applied to dendrimer studies. Depending on the size either the 
dendrimer or the biomolecule can be described as the docking center. The docking site can 
be defined either in a small space of the dendrimer or in the whole structure (middle 
figures). The generated docking structures can then be submitted to MD simulations or the 
conformations from MD simulations can be used to dock the molecules (Bottom figures).  
time
Protein
30 bp DNA duplex
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G6Attachment of dendrimer to the agonist 
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In contrast to this approach, the full size partially glycosylated and non-glycosylated (negative 
control) PAMAM dendrimers G3.5 were used as ligands in rigid docking against human MD-2 
glycoprotein as a target. This was achieved using both Patchdock and Hex software for docking. Since 
both software packages were based on rigid docking, twenty different dendrimer conformations were 
obtained from MD. The partial glycosylation was found to promote better shape complementarity and 
showed a higher number of interactions compared to the non-glycosylated form. The docking 
interaction calculated with HEX showed that the partially glycosylated dendrimer co-operatively 
interacted with residues in the MD-2 entrance pocket revealing that not only shape but more 
importantly the electrostatic interactions were crucial for the biological activity of these dendrimers. 
The docked structures were then used as base for the MD simulations [52]. 
These examples illustrate the usefulness of docking methods to estimate free energy bindings, 
identify binding site locations and even to explore the potential of a dendrimer as a therapeutic agent. 
In fact, docking can be used as a preliminary filtering tool to optimize dendrimer structure. 
Specifically, it can be used to determine the potential use of a dendrimer to bind a guest molecule. 
Furthermore, if the in vivo behavior of the dendrimer is known and is interesting, docking methods can 
be used to evaluate a potential range of drugs that would fit the desired in vivo profile. Docking can be 
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used to check if drugs can be incorporated into the dendrimer in a similar process that is used in high 
throughput in silico screening performed for protein targets.  
3. Modeling Dendrimers for Biomedical Applications 
The design and development of dendrimers for biomedical applications is accelerated when there is 
an understanding of some of their properties in a physiological milieu. Molecular modeling techniques 
can provide the means to gain an increased understanding of important molecular structural features 
and dynamic behaviours that are fundamental to a biomedical application. Many methodologies have 
been developed and validated to model these molecules with good correlation with experimental results. 
3.1. Impact of Solvent and Dendrimer Topology 
One of the primary applications of molecular modeling for the study of dendrimers has been to 
better understand conformational behaviour in solution. As expected dendrimer structure and topology 
appears to be dependent on the factors inherent to the dendrimer (generations, monomers length and 
their chemical properties) and factors related to the solvent (type of solvent, salt type and ionic 
strength) [107,110]. The combination of these factors affects the binding pockets to establish  
host-guest interactions as well as the possible moieties at the surface of dendrimers.  
There has been a particular emphasis to understand the behaviour of PAMAM dendrimers in 
solution. This class of dendrimer is commercially available and there is vast array of experimental data 
that can be used for comparison. As a result, different levels of theory and force fields have been 
applied to PAMAM dendrimers from which Rg values have been measured and compared to 
experimental data (see Table 2). Although PAMAM dendrimers can have limited biomedical 
applications due to their inherent toxicity at higher generations (see [31]), these studies are important 
for methodology development and validation. Notably, PAMAM dendrimers exhibit different 
protonation levels at different pH value since they are composed of both primary and tertiary amines. 
Experimentally, it has been determined that for G4 [111] and G8 [112] the size of the dendrimers is 
independent of the pH with a variation of 4% and 2% respectively.  
Since representing water and ions explicitly can be computationally demanding, the use of lower 
levels of theory is often considered and the solvent is treated implicitly. A way to overcome this 
problem is to perform an all-atom simulation with explicit solvent on a smaller generation and 
compare the radius of gyration and atom distribution with simulations performed with different 
implicit parameters [87]. From such studies it was found that the use of a distance-dependent dielectric 
constant without a cut-off distance had the best similarities to the explicit simulations for the neutral 
and low pH dendrimers and was reasonable for the high pH. However, when comparing the values of 
Rg obtained for a G4 dendrimer, this model was not able to predict the size invariability, previously 
was determined experimentally at different pH values [111]. One key aspect is that the implicit 
treatment of water may not fully represent the solvation to the necessary degree, including the 
diffusion of water molecules inside the dendrimer branches that contribute to swelling [110].  
A good solvent system is essential for a reliable prediction of dendrimer size and conformation, and 
the evaluation of solvent penetration into dendrimer void spaces [113]. The water behaves differently 
depending on its position to a dendrimer. In the case of PAMAM dendrimers three classes of water 
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have been described: (i) buried water; (ii) surface water at the dendrimer-solvent interface and  
(iii) bulk water (i.e., solvent) [113,114]. Water molecules are enthalpy favored near the dendrimer and 
buried water has lower entropy in relation to the bulk water. Therefore, the binding of a water 
molecule to a dendrimers molecule results in release of this difference of free energy [114]. 
Water molecules penetrate inside the dendrimer and compete for H-bonds between dendrimer 
residues [89,110]. However, other factors such as the force field employed may contribute to the 
correct prediction of experimental data (see Table 2). Recently, a study using all-atom simulations of 
PAMAM G4 with explicit solvent and counter-ions employing the DREIDING force field with 
optimized parameters (e.g., hydrogen bonding Cl−-+HN(CH3)3) [85] was able to predict the behaviour 
of these dendrimers at different pH. These simulations were not only able to predict the low variability 
of Rg (swelling of 4.9%) at different pH values, but they also elucidated the conformational 
mechanisms that the dendrimer underwent. It was observed by measuring the radial density 
distribution that the dendrimer underwent an intermolecular transition from a “dense core” at high pH 
to a “dense shell” at low pH. This mechanism of mass redistribution is important to interpret for 
example the encapsulation and the possible release mechanism of drugs from such dendrimers. This 
kind of behaviour of conformational change triggered by pH changes is highly desirable for 
intracellular delivery and is critical for the development of stimuli responsive polymers. 
Different types of solvent can also promote structural modifications of the dendrimers that impact 
their properties. MD simulations were conducted in explicit solvent for dendrimers with a linear PEG 
chain in the core. Depending on the solvent (methanol vs. THF) the PEG was more extended or more 
compact in order to increase or decrease the interaction with the solvent. This resulted in burying of 
the dendrimer [35]. Although the solvent accessible surface area (SASA) was not measured for these 
dendrimers, the measurement of the radius of gyration revealed that in methanol the PEG core extends 
outwards and tends to wrap around the dendrimer as observed in the snapshots from the last frames of 
simulation. This study provided rationale for experimental results [115] where two structure forms 
were suggested (wrapping around vs. loops to the exterior). This is important as it gives a mechanistic 
view of the changes of the material in different solvents and can be used design dendrimers that 
respond differently in different solvent systems. Likewise, a PAMAM G5 dendrimer with amine 
terminal groups and 90% acetylation was simulated in explicit water and methanol using the General 
Amber Force Field (GAFF) in the presence of counter-ions. Measurements of the radius of gyration 
showed that the presence of acetylation promoted the dendrimer to shrink and become more compact 
compared to the non-acetylated dendrimer. The size of both dendrimers were similar to what was 
observed experimentally (2.50 nm (SEC) vs. 2.51 nm (MD) for G5 PAMAM and 2.35 nm (SEC) vs. 
2.11 nm (MD) for PAMAM G5 acetylated and in methanol 2.41 (SAXS) vs. 2.57 nm (MD) for 
PAMAM dendrimer [89]).  
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Table 2. Non exhaustive list of PAMAM dendrimer simulations and their radius of gyration. For comparison the experimental values obtained 
by SAXS and SANS are displayed on top. 
FF Solvent G0 G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 Source 
SAXS Methanol    15.8 17.1 24.1 26.3 31.9 40.3 49.2 57.4 [86] 
SAXS Methanol 4.0 7.9 11.8 15.09 18.60 23.07 27.50 32.11 38.58 - - [116] 
SANS D2O - - - - 20.90–21.30 - - - - - - [117] 
SANS D2O pH 4.97–10.25 - - - - 20.64–21.58 - - - - - - [111] 
SANS D2O pH 4.7–10.1 - - - - - - - - 38.1–40.7 - - [112] 
SANS Different solvents - - - - - 22.1 - - 32.8–43.8 - - [118] 
DREIDING Vacuum 4.93 7.46 9.17 11.23 14.50 18.34 22.40 29.09 36.42 46.03 55.19 [10] 
DREIDING optimized QM Water explicit - - - - 21.07–22.11 - - - - - - [85] 
DREIDING Water implicit 4.97 7.03 9.77 13.01 16.36 21.67 27.62 - - - - [35] 
DREIDING Water explicit High pH - 7.4 11.5 12.9 16.9 20.3 24.7 30.1 - - - [119] 
DREIDING Water explicit Low pH - 9.4 13.6 17.2 21.1 26.1 32.5 37.57 - - - [119] 
CHARMM 27 Water explicit - - - 15.33 21.04 25.50 30.18 - - - - [95] 
AMBER Water explicit pH 7.4 - - - 16.25 18.8–20 22.43–22.9 27.2 - - - - [50] 
AMBER Water explicit pH 5 - - - - 21.0 24.2 28.9 - - - - [50] 
DREIDING Water explicit pH 4–12 - - - - -  - - 37.8–43.11 - - [120] 
Coarse-Grained (MARTINI) Water explicit - - - - 20.1 25.6 - - - - - [59] 
Coarse-Grained Water explicit - - - 13.1 - 23.20 - - - - - [60] 
DREIDING Water explicit pH 12 - - - - 16.78 20.67 26.76 - - - - [110] 
DREIDING Water explicit pH 7 - - - - 17.01 22.19 27.28 - - - - [110] 
DREIDING Water explicit pH 4 - - - - 19.01 24.76 30.89 - - - - [110] 
CVFF Water implicit Low pH - - 16.6 22.8 29.9 38.0 46.8 - - - - [87] 
CVFF Water implicit Neutral pH - - 14.5 19.7 26.7 32.8 41.3 - - - - [87] 
CVFF Water implicit High pH - - 8.4 11.6 14.8 18.3 24.2 - - - - [87] 
OPLS Vacuum - - 11.0 13.7 - - - - - - - [121] 
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Although water molecules led to more hydrogen bonding between the dendrimer and the solvent, 
the number of intra-molecular hydrogen bonds was found to be similar both in water and methanol. 
From the snapshots used to illustrate the H-bonds in the dendrimer, several cis-conformations of the 
amide bond can be observed. This could have resulted from not setting constraints to trans 
configuration while generating the dendrimer. Because of the large size of the dendrimer it would be 
hard to return to the most stable conformation. The results of this effect on the overall structure cannot 
therefore be assigned. Measurements of the relative shape anisotropy showed that both dendrimers 
correlated well the spherical model and that it was not affected by the solvent [89]. 
A combination of the effect of the solvent and the topological features of dendrimers was studied 
using coarse-grained MD with different dendrimers’ generations (G4 to G7), different spacer lengths 
(1 to 6 molecules) and charges (neutral, partially and fully charged). From these structures it was 
observed that neutral dendrimers had a more spherical and compact structure compared to charged 
dendrimers, which had void spaces in their interior. It is expected that the resulting space left would be 
available to encapsulate drugs. It is also expected that with increasing size, higher volume will be 
obtained. Experimentally it was found that the increase in PAMAM generation from 4 to 6 increased 
the internal volume [122], which could also be observed by the measurement of solvent excluded 
surface of the simulated dendrimers [110]. Modifying the size of the spacer in the core was also 
observed to have an enormous effect on the size of the dendrimer as well as on its internal structure 
which changes from a compact almost sphere to a “blob-like” structure [123]. 
Another example where modeling can be crucial for designing dendrimers as potential drug carriers 
was studied in two families of an asymmetric (poly(L-lysine) and symmetric cationic G4 dendrimers  
at different pH. Both dendrimers were built in Starmaker and parameterized using the OPLS-AA FF. 
The simulations were performed with explicit solvent and counter-ions in NAMD for 10 ns.  
Both protonated dendrimers exhibited extended conformations (40% and 60% higher Rg for the SPAM 
and PLL respectively) whereas, in the neutral state a significant back-folding of terminal chains was 
observed [94]. The PLL dendrimer showed a higher deviation from the extended spherical form 
showing that the asymmetric nature of the dendrimer might facilitate other type of conformations.  
Predicting this kind of “smart” or stimulus triggered behaviour has tremendous impact for 
applications as drug delivery systems since new dendrimers can be designed to encapsulate drugs in 
specified conditions (e.g., pH or other type of solvent), which then in vivo prevent the burst release 
from the entrapped drugs inside. It can also potentiate the design of a stimuli-responsive mechanism 
such as pH-triggered release, which can be useful for intracellular release. 
3.2. Impact and Versatility of the End Groups 
Because of the hyperbranched topology of dendrimers, there are many end groups that can be 
tailored to participate in multiple specific or non-specific interactions simultaneously. A common 
practice for overcoming the potential toxicity of multiple charges at the surface has been the 
attachment of other groups such as acetyl, PEG or lipid moieties. The end groups can also be modified 
to carry targeting moieties, e.g., folic acid [80].  
End group modifications can influence the overall dendrimer structure resulting in altered  
host-guest interactions or inefficient display of the targeting moieties. As an example, a common 
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observation for PAMAM dendrimers is the back-folding of the terminal end groups [110,120,124] as 
measured from the density distribution of the terminal groups from the centre of mass. If the intended 
goal is to protect a labile molecule from the external environment, this type of structure would be 
effective. However, in the case of a linked moiety (e.g., targeting molecule) this kind of structural 
arrangement would, most likely, be ineffective (see Figure 7). Both cases can be elucidated by 
molecular modeling, which help with structure design. Modeling approaches can sample the location 
of these groups and their available surface area to the solvent and provide some insight about the 
potential of modified end groups to be available to interact with a biological target.  
Figure 7. Availability of the substituted terminal glucosamine groups on PAMAMs’ 
surface. Reprinted from [90].  
 
With the intent of examining the effect of terminal capping groups on the exposition of the folic 
acid to interact with the receptor, MD simulations were carried with CVFF in implicit solvent treated 
with a distance-dependent dielectric constant [80]. PAMAM G5 dendrimers with folic acid and 
terminal groups composed of amine, hydroxyl, carboxyl and acetamide, simulations showed that both 
dendrimers with charged groups internalized folic acid groups as measured by the mean distance of 
folic acid from the centre of mass and compared to the Rg. In contrast, in the case of the acetamide 
derivative the surface groups were extended away (mean distance of 26.7 Å vs. 19.8 of the Rg) 
suggesting potential capacity to interact with the receptor.It was suggested that the hydroxyl terminated 
dendrimer had higher exposition of the folic acid to the surface (mean distance of 27.2 Å vs. 21.8 of 
the Rg), although not as pronounced as in the case of acetamide derivative. Altogether these measurements 
correlated directly with the cell internalization assay of these dendrimers to KB cells [80]. 
Similarly, all-atom simulations with CHARMM 22 force field on PAMAM G3 terminated either 
with amine, hydroxyl groups or hydroxyl groups with four methotrexate (MTX) molecules were tested 
for the availability of MTX. The measurement of Rg for PAMAM-OH and PAMAM-MTX was 
smaller compared to PAMAM-NH2 (13.1, 14.0 and 18.8 Å respectively). Although more collapse 
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topologies (in comparison to PAMAM-NH2) were obtained, the snapshots of the equilibrated 
simulations indicated that the MTX remained at the surface. This result correlated positively with the 
binding affinity of these dendrimer found experimentally [125]. 
Considering a different approach, MD simulations were conducted to design dual labelled dendrimers 
in which the probes do not interfere with one another (by quenching or any other way) [126]. A 
PAMAM dendrimer was functionalized with both carboxy-fluorescein and tetramethyl-rhodamine. 
PEG spacers were introduced in order to study if it was able to maintain both fluorophores at a certain 
distance. The simulations were carried out in AMBER 11 with either no PEG or 44 monomers of PEG 
and an explicit water model was used with enough ions to neutralize the charges of the dendrimer 
together with 150 mM of NaCl to mimic experimental conditions. The analysis of the radial 
distribution function and fluorescein-to-rhodamine distance both suggested a suitable distance between 
dyes only in the presence of the PEG spacers. These results were in accordance with the quantum yield 
measured by optical spectroscopy [126]. Based on the validation by the modeling studies these 
dendrimers were used to probe the physiological/pathological microenvironments by measuring the 
fluorescence and making the assumption that both probes did not interfere with one another.  
This type of approach has good potential to develop diagnostic tools. A practical and very beneficial 
application of this kind of molecular modeling design of dendrimers with several types of sensing 
probes would be for example in guided surgery by luminescence of tumour cells [127]. Dendrimers 
could be design to have sensing probes with targeting groups to selectively be internalized by cells. 
The probed would light up differently depending on whether or not they are tumour cells. This difference 
would help to identify areas surrounding the removed tumour and therefore a more efficient removal 
would be obtained instead of removing healthy tissue surrounding just for precaution. This approach 
would also be useful to identify metastasis that would not be identified by other methods [127].  
Poly(ethylene glycol) (PEG) chains are also commonly used in biomedical applications to stabilize 
macromolecules (e.g., proteins) and increase their half-life. Coarse grained simulations with MARTINI 
FF in GROMACS were used to study PAMAM dendrimers of different generations linked to PEG 
chains of different size in order to study the conformation and aggregation of these dendrimers in 
solution [92]. Although CG simulations use a lower level of theory the measured Rg values was in 
close agreement to those measured experimentally (theoretical values: 5.98, 6.65 and 740 vs. 5.67, 7.06 
and 7.67 nm measured experimentally) reassuring the usefulness of the predicted model. Altering the 
size of PEG chains in the PAMAM surface showed remarkable differences. When higher MW PEG 
chains were used, a completely coverage of the dendrimer was achieved and, although PEG tends to 
extend towards water, the spherical characteristics of dendrimers was maintained. Simulations up to 
400 ns of binary systems of both lower and higher MW PEG chains revealed that no aggregation 
between two dendrimers was observed as measured by the distance of both centres of mass [92].  
This interesting approach allows the study of the impact of surface modifications (e.g., linkage of 
targeting groups such as antibodies to the end of PEG chain) and the prediction of dendrimer 
behaviour to aggregate in solution that would make them ineffective. This kind of approach was also 
useful for the design of dendrimers with bio-labile linkages that were available to the solvent so that 
the degradation could occur [72]. Triazide dendrimers with paclitaxel were linked to different number 
of hexaPEG, nonaPEG or dodecaPEG and simulated in AMBER with parm99 all-atom force field. 
These simulations were performed to ensure that the bio-labile linker was available at the surface so 
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that it could be degraded and release the anti-cancer drug. Measuring the RDF it was found that 
increasing the PEGylation lead to a significant increase of PEG at the location of the linker [72]. 
Nevertheless, for all types of PEGylations, paclitaxel was found to be homogeneously distributed and 
close to the surface with only a small number of molecules back-folding.  
Using a different approach, G5 dendrimers with different terminal groups, at different pH values, 
were build using Insight II software and simulated using CVFF to correlate the conformation of the 
dendrimer with the release and efficacy of an anticancer drug [81]. For this, seven 2-methoxyestradiol 
(2-ME) molecules were randomly incorporated in the simulation box. The position of 2-ME was 
measured from the centre of mass and was found to be farther for G5 with amine terminal groups and 
N-Glycine-OH. Except for G5-carboxyl all other structures exhibited open structures, which could  
be attributed to the release of the drug. These findings were consistent with the lower toxicity of  
G5-carboxyl observed in KB cells as the collapse structure would not allow the release. Although only 
a short simulation of 100 ps was performed the consistency with the structure obtained was achieved. 
However, the authors did not provide rationale for the superior encapsulation of 2-ME by ACE 
terminated dendrimers found experimentally, which might be caused by the aggregation of 2-ME 
inside the dendrimer that is neutral at this pH with the relative collapse of the structure in comparison 
to amine and carboxylic terminated dendrimers [81]. 
3.3. Dendrimers Interaction with Lipid Membranes 
Despite the tremendous developments of methods to study dendrimers, it is still a great challenge to 
develop novel dendrimers. Regardless of the applications for which dendrimers are used in 
nanomedicine, the fundamental knowledge of how these interact at the interface with cells is 
mandatory. Designing smart entities able to deliver their therapeutic payload to the site of action and 
circumvent physiological barriers is a promising strategy to achieve better therapeutic efficacy. 
Dendrimers interact with cells, and more specifically with the lipid bilayer. Cellular membranes are 
complex systems and a number of techniques have been used to address the interaction of dendrimers 
with these biomolecules including AFM, DLS, NMR, DSC and Raman Spectroscopy [128–132]. 
However, this is a difficult task, in part due to the extreme complexity of biological membranes. They 
contain a tremendous number of different lipids and proteins able to modulate the interaction between 
the dendrimer and the membranes.  
Nevertheless, the results observed for model membranes have been well correlated with toxicity 
observed on cells. It is generally acknowledged that polymers with high density of cationic charge are 
more likely to cause disruptive effects on membranes [133]. In the case of PAMAM dendrimers these 
were found to have high deleterious effects both in model membranes [128,129] and cells [134,135]. 
In fact they were found to cause toxicity in a concentration, terminal charge density and generation 
dependent manner [136]. During this interaction, either the dendrimer creates holes (Figure 8), disrupts 
the membrane (particularly at higher generations) or is well accommodated in the lipid bilayer. 
Although this effect may mediate a higher cell transfection or even be useful as an anti-microbial 
activity [82,137] it is not suitable for drug delivery systems. Despite the experimental data that has 
been obtained, molecular dynamics simulations have been useful to elucidate the molecular 
mechanisms underlying these results [37,74,138]. In fact, molecular simulations allow testing 
Molecules 2014, 19 20447 
 
 
hypothesis that would be impossible to test experimentally. As an example, simulations of cationic G5 
and G7 dendrimers of different concentrations on a DMPC membrane were tested with either short or 
long PME electrostatic interactions [53]. For the short PME electrostatic range no bending or insertion 
of the dendrimers was observed, suggesting that the long-range electrostatic interactions (i.e., interactions 
with the inner layer of the membrane) are indeed necessary for prediction of dendrimer toxicity. 
Figure 8. Proposed mechanism for high generation of PAMAM dendrimers; there is an 
initial attraction to the membrane governed by several forces (e.g., electrostatic); once the 
dendrimer is near the membrane the inner leaflet promotes interactions with the dendrimer. 
For high generation, the dendrimer is not able to flat and causes perturbation on the 
membrane leading to the formation of a vesicle encasing the dendrimers with subsequent 
formation of a pore. 
 
Until recently, molecular dynamics using all atoms and explicit solvent systems have been restricted 
by the size of the system. Although there has been great progress in computational sciences, this type 
of simulation is still limited in terms of timescale. Coarse-grained models loose some finer details such as 
hydrogen bonding but they provide an alternative to full atomistic simulations. Recent reports show they 
can successfully be used to generate predictive models of dendrimer-membrane interaction [53,77,139]. 
In general terms, from the various simulation studies, dendrimers first interact with lipid 
membranes through different forces and depending on their composition, size and concentration, as 
well as, the properties of the membrane, different phenomena can occur [60,74,77,138,140].  
In order to settle the influence of size on the disruptive mechanism of PAMAM dendrimers in the 
lipid bilayers, coarse-grained simulations of G3, G5, G7 and G9 were performed with different 
tensionless membrane models (DMPC and two membranes with shorter and larger tails). The radius of 
gyration measurement showed that G3 and G5 dendrimers were able to flatten upon interaction of 
interaction with the DMPC membrane [77]. This effect has been widely observed in simulations 
including in all-atom simulations for differently terminated G3 dendrimers (amine, carboxyl and acetyl 
groups) [138] and has been attributed to the attempt of the dendrimer to maximize the interactions of 
all branches. However, at higher generations the flattening process upon interaction with the membrane 
is less evident due to the density of branches making it thermodynamically unfavorable [141]. As a 
result, the dendrimers keep their globular rigid conformation resulting in the pulling of the membrane 
instead. Upon interaction with the membrane, no pore formation was observed with for the PAMAM 
G5 in DMPC membrane [77]. This is clear agreement with experimental data where PAMAM G5 was 
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only able to expand existing defects but does not form new ones [133]. The measurements between the 
dendrimer and the membrane in the z-axis were evaluated as a measurement of dendrimer 
permeability. Dendrimers G3 and G5 showed small values consistent with the adsorption model in the 
membrane for all types of membranes. On the opposite side, G7 and G9 values were consistent with 
the embedded model in the membrane. The permeability also increased with the decrease in the tail 
size. From the snapshots, presented by the authors in the original publication, it is possible to observe 
significant distortions induced in the DMPC membrane while for shorter tail size membranes the G7 
and G9 induced the formation of dendrimer-filled vesicles. On the contrary, for larger tail sizes the 
distortions induced by these dendrimers were smaller [77]. 
Dendrimer concentration has been other factor that showed to increase the toxicity of PAMAMs, 
experimentally. To explore this effect on membranes, a PAMAM G7 and G9 on a DMPC membrane  
were simulated using different simulation box sizes. These results showed that by increasing the  
area of the membrane, the cavities induced by the dendrimer became smaller [77]. However, this type 
of “dilution” may not capture the collective behavior of more than one dendrimer in the near space 
(higher concentration) as it only considers one dendrimer at the time. To overcome this, simulations of 
both positively charged and acetylated dendrimers were simulated in clusters in a DMPC bilayer [53]. 
An interesting observation from these simulations was that only 4 positive PAMAM G7 dendrimers 
were necessary to induce a strong bending on the membrane with insertion of some branches and pore 
formation while it required 16 positive G5 to induce some bending and insertion to the membrane. 
Furthermore, these effects were not observed for acetylated G5 dendrimers but these dendrimers 
aggregated instead [53]. Since the terminal groups can have such impact on dendrimers interaction, all 
atom simulations with implicit solvent were performed. A smaller system of a PAMAM G3 dendrimer 
with different terminal groups (amine, acetyl and carboxylic groups) on a DMPC bilayer were used to 
study the energy component involved in these interactions. The free energy binding was found to be 
47, 36 and 26 kcal/mol for the PAMAM-carboxylic, PAMAM-amine and PAMAM-acetyl respectively 
and the attractive force was similar for both charged dendrimers [137]. These results are expected due 
to the zwitterionic character of DMPC lipid and therefore charged dendrimers interact more favorable 
than acetylated neutral ones.  
Recently, a full all atom simulation was performed with a PAMAM G3 with amine terminal  
groups on a DPPC membrane and a discrepancy of 15 kcal/mol larger over the previous simulation 
was found. This result suggested that the explicit treatment of water significantly affects the adsorption 
thermodynamics as it contributed to the more entropic favorable interactions by releasing water 
molecules while pushing the dendrimer out of the water phase [142].  
Lipid aggregation can also lead to the formation of fluid and gel phases. Experimentally AFM 
measurements of PAMAM G7 showed that the disrupting mechanism was abolished in gel phase of 
DMPC membrane [143]. Coarse-grained simulations of PAMAM G3 and G5 were simulated in DPPC 
bilayer at different temperature (277 K and 310 K) to simulate a more ordered phase compared to a 
more disordered phase. The results showed that during the simulation time no insertion of PAMAM 
G5 was observed at 277 K, contrary to the insertion observed at 310 K [60]. Similarly, all atom 
simulations of PAMAM dendrimers differently terminated (amine, carboxyl and acyl groups), with 
implicit solvent treatment, tested the fluidity of the membrane on dendrimers interaction. In this case, 
the gel phase was simulated by immobilization of the lipid tails from an equilibrated fluid phase 
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DMPC bilayer. In the case of the fluid membrane a depression was formed to accommodate the 
dendrimer while the dendrimer flatted to extend the number of interaction. On the contrary in the gel 
phase the dendrimers remained at the surface without inducing any kind of deformity.  
Cell membranes, however, are much more complex than a simple unique lipid bilayer. For instance 
they are composed of different lipids and the combination of different lipids can lead to different 
properties. To address this issue, a recent study using coarse-grained description of three types of lipids 
(DPPC, DPPE and DPPS) were tested in different ratios (to mimic erythrocyte membrane) with G4 
and G5 PAMAMs [59]. The asymmetry of the membrane showed to be correlated with the ability of 
the dendrimer to insert on it. In the case of symmetric membrane, PAMAM G4 remained at the surface 
of the outer leaflet. These differences were attributed to the electrostatic attraction between the inner 
leaflets of the membrane towards the dendrimer. Increasing the percentage of DPPS from 10% to 50% 
showed a decrease in the distance between centre of mass between dendrimer and the membrane, 
meaning that the insertion of the dendrimer was higher. Complementarily, the order parameter of the 
phospholipid tail (a measurement of the movements of lipid bilayers) revealed that the incorporation of 
the dendrimer decreased the lipid order. The PAMAM G5 created more perturbation in the lipid order 
that resulted in an observed the transient formation of a pore [59]. The type of lipids on the membrane 
can also have a specific role on the interaction with dendrimers. Using coarse-grained simulations of 
PAMAM G3, G4 dendrimer in bilayers composed of DPPC mixed with dipamitoylphosphatidyl-glycerol 
(DPPG) it was found that the dendrimers promoted the diffusion of the oppositely charged DPPG lipid 
from the inner to the outer leaflet [144,145]. This formation of microdomains of lipid rafts was also 
observed for PAMAM G7, G8 and G9 interacting with a bilayer mixture of 1,2-dimyristoyl-sn-
glycero-3-phosphoglycerol (DMPG) with DMPC (3:7 ratio) lipids using coarse-grained simulations 
with the MARTINI force field. This simulation showed that the number of DMPG lipids near the 
dendrimer increased with the increase in dendrimer generation and a significant bending in the 
membrane was observed [146]. Overall these simulations are consistent with experimental data on 
dendrimers’ toxicity. Dendrimers, particularly high in generation and cationic, can cause deleterious 
effects by disturbing the membrane. The particular interest of performing molecular dynamics is not 
only to explain how these effects occur but also to prevent them by designing structures that do not 
favour these types of interactions. In particular, it would be of high interest to develop dendrimers that 
could efficiently encompass a mechanism of lysosome escape without the disruptive mechanism. This 
would be useful for a vast range of therapeutic molecules including gene therapy.  
3.4. Modeling Dendrimers for Drug Delivery Applications 
Combining the power of explanation of molecular mechanisms and construction of predictive 
models that can be applied to other kind of dendrimers gives a significant advantage to perform 
optimizations before even starting the synthesis of novel dendrimers. In terms of drug delivery 
applications, there are several factors where modeling and molecular dynamics can provide useful 
insights on how to optimize these carriers. Some of these factors include: (i) the stability of  
drug-dendrimer complexes; (ii) the strength of interactions that might compromise drug release;  
(iii) the availability of the targeting groups for interaction; (iv) the exposure of labile molecules to the 
solvent; (v) elucidate which forces govern the dendrimer-drug interaction and if those can be changed 
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and finally; (vi) if can the dendrimer withhold a significant number of molecules to make it attractive 
to drug delivery. The detailed analysis of these factors is also crucial to understand how these 
dendrimers will perform in vivo.  
In the field of drug delivery, dendrimers could be designed to a vast range of drug molecules  
in order to solve problems such as solubility, drug release and targeting. Essentially, drugs can be 
incorporated into the dendrimer either covalently (e.g., prodrug) or non-covalently (surface or internal 
cavities). As observed in the classical structural behaviour of PAMAM dendrimers, the hydrophobicity 
of the interior (see Figure 9) can be modulated through pH and salt variations. These variations can be 
used to ascertain the conditions for encapsulation that will be different from the medium in which they 
are going to be released.  
Figure 9. PAMAM dendrimers’ hydrophilic surface (blue) and hydrophobic core (orange). 
Adapted from [45].  
 
A classic example is the delivery of nonsteroidal anti-inflammatory drugs (NSAIDs). The particular 
interest in these drugs lies in their potential for encapsulation and controlled release. This would be 
technological beneficial as a prolonged analgesic effect could be achieved without increasing side 
effects such as ulceration. In particular, ibuprofen is a common model drug to test new drug delivery 
systems due to its small size and being a class II drug (high permeability but low solubility) and hence 
the availability is limited by their solvation rate. Experimentally, it was shown that PAMAM 
dendrimers were able to solubilize ibuprofen [147,148], it was shown that this effect was dependent on 
the pH and generation of the PAMAM dendrimers.  
To probe how the interaction occurs, a PAMAM G3 was simulated at different pH with  
ibuprofen [54]. Using all-atom MD simulations, with the AMBER FF, the drug molecules were placed 
in the proximity of the dendrimer. The analysis of atom distributions showed that ibuprofen could 
penetrate more to the dendrimer core than water. Unlike at basic and neutral pH, at acidic pH the 
ibuprofen is located homogenously throughout the dendrimers’ surface but cluster formation was 
observed. The measurement of the average distance between the ibuprofen and the PAMAM center of 
mass as a function of time also revealed a constant value at neutral and basic pH values, meaning the 
complexes formed are stable. At neutral pH conditions, hydrogen bonds are established between the 
dendrimer and the ibuprofen and this complex is mainly formed at the surface. On the contrary, at 
acidic pH, the ibuprofen diffuses away, this is seen by the increased values of mean distance [54]. This 
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was consistent with the experimental results where the solubility of PAMAM dendrimers decreases 
under acidic conditions [147].  
In another study, the calculation of dendrimer-ibuprofen complexes with incorporation of  
different amounts of drugs was evaluated using MM2 calculations. From these calculations it was 
observed that incorporating more than 16 ibuprofen molecules inside the dendrimer was energetically 
unfavorable [107], which is a similar value to the one found experimentally (14 ibuprofen molecules) 
for a PAMAM G3 [148].  
Similarly, PPI G5 were simulated with Bengal rose with the DREIDING force field and these 
simulations revealed that depending on the drug:dendrimer ratio, the number of molecules found in the 
interior would vary as measured by distance from the center of mass of each molecule, in clear 
agreement with experimental data [84].  
This kind of study can also be applied to other drugs of the same class, to study, which one showed 
better binding affinity to the dendrimer. Thus a predictive model can be built of the drug more suitable 
for the carrier. In this case the design is based on the selection of the drug rather than the optimization 
of the carrier itself. In order to have a more accurate calculation of the binding energies of four 
different NSAIDs drugs, semi-empirical methods (PM6-DH+) were used [149]. However, this 
approach is limited by the size of the dendrimer to be included in the calculations. To overcome this 
limitation, several branches of the dendrimer were taken separately from structures originated from 
MD simulations in NAMD on PAMAM G4 with CHARMM FF. The conformational pairs between 
branches and drug were then generated by a Monte Carlo method and the energetics calculated using 
semi-empirical methods (PM6-DH+). The energy values obtained were directly correlated with the 
affinity degree found experimentally (naproxen > ketoprofen > ibuprofen > diflunisal) [149].  
In a similar study, but applied to anti-cancer therapy, MD simulations were carried out to assess the 
molecular interactions between a series of 24 cytotoxic drugs and a G4 PAMAM dendrimer. The 
results indicate that the majority of drugs show high thermodynamic stability. The complete set of 
drugs showed to effectively interact with the dendrimer in an exothermic fashion, with bleomycin, 
orlistat and porfimer being the ones that most strongly interact with the PAMAM dendrimer [150].  
These are encouraging results has one can predict from a pool of interesting drugs which ones will 
fit best into the features of a given dendrimer. This kind of approach has been tested on PAMAM G5 
dendrimers with different drugs (salicylic acid, L-alanine, phenylbytazone and primidone) [98]. These 
drugs were docked to the dendrimer via AutoDock Vina and then the best scoring conformations were 
selected for MD simulations using AMBER with explicit water solvent. Umbrella samplings were 
performed between the center of mass of the dendrimer and the drugs. When plotting the potential 
mean force (PMF) among all drugs studied L-alanine showed lower free energy (better ability to be 
released) followed by salicylic acid, primidone and phenylbutazone. However, taking into account the 
experimental data, although L-alanine and salicylic acid had a lower free energy (semi-empirical 
calculations) they were difficult to encapsulate in the dendrimer due to absence of nonpolar groups. 
This is due to less van der Waals contributions and the hydrogen bonding that did not contribute 
significantly to the free energy barrier. The PMF was also found to be less when the drugs are bound to 
the non-protonated dendrimer. The authors suggest that drugs should be encapsulated at higher pH and 
once in physiological pH they will be more tightly bond making the release controlled [97].  
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Proposed alteration of pH to modulate the interaction, encapsulation and release of drugs was 
observed from MD/MM simulations of PAMAM G5 and folic acid-terminated PAMAM G5 with 
tramadol and morphine [96] as well as PPI dendrimers G5 with Famotidine and Indomethacin [44] 
where the affinity of these drugs decreased with the decrease in pH. Similarly, PAMAM G4 equilibrated 
using MM+ FF were docked with resveratrol, genistein and curcumin [55]. The MD simulations 
revealed that the free energy binding followed genistein > curcumin > resveratrol which was in different 
binding constants determined experimentally which followed the order of curcumin > genistein > 
resveratrol. The difference between the calculation of energy of binding and the binding constants 
found experimentally was attributed to the difficulty of the drug to access the interior of the dendrimer.  
A way of accounting for this kind of behavior could be by using adaptive biasing force methods. 
This kind of approach was recently used to study the association of nicotinic acid with a PAMAM G3 
at different pH (pH 3 and pH 6) [95]. Using a biasing force method the drugs were constrained  
in the z-axis to make sure that the drug moved along the selected sample direction but were  
allowed to move freely through the x and y axis. The energy profiles showed that the nicotinic acid 
interacted better with G3 at higher pH with an energy difference of −1 to −2.5 kcal in comparison to  
3-pyridiniumcarboxylate and that this interaction was more favorable at the surface than in the  
interior [95]. Since nicotinic acid is also a poorly soluble drug and needs to be delivered to the interior 
of the cells, determining at which conditions it can be better encapsulated in the dendrimer and its 
location served as a guide future optimization of the carrier.  
A different kind of approach was used to study the stability of complex formation between  
poly(L-lysine) G6 dendrimers with the anticancer drug doxorubicin to evaluate the potential as a drug 
delivery system. The drug-dendrimer complex was found to be favorable at 300 K but dissociated 
upon heating up to 1000 K. However, once the system was cooled again it reassembles again showing 
the favorable interaction between these two molecules and hence favorable for controlled release [83].  
One of the most promising areas for the use of dendrimers as drug delivery systems is gene 
delivery. Dendrimers have long been recognized as potential carriers to nucleic acids due to their 
highly expressed positive charge, which allows them to form polyelectrolyte complexes (also known 
as dendriplexes). Both experimental and all-atom MD simulations have shown that nucleic acids have 
the ability to wrap around the dendrimer in a process that depends both on size and charge ratio. In this 
particular application MD simulations can probe with substantial detail whether a dendrimer will be a 
suitable carrier. The mechanistic details that can be probed, including how strongly the nucleic acid 
binds to the dendrimer, which will impact on the release. If the binding is too strong, the release could 
be jeopardized, however, if the interaction is not as strong, the nucleic acid will be available to be 
cleaved in solution.  
MD simulations were carried out in AMBER7 with AMBER95 FF for ssDNA and the DREIDING 
FF for the dendrimer, with different levels of protonation. The various dendrimers were docked to the 
major groove of an ssDNA. Further simulations were carried out in explicit water and counter ions 
were added to neutralize the system. The simulations showed that for G2 and G3 the charge ratio was 
not enough to complete wrap the ssDNA onto the dendrimers, as evidenced by the radius of gyration 
of the complexes. On the other hand the G4 dendrimer was large enough to neutralize the charges of 
the ssDNA and promoted the collapse of the latter into the surface. This led to the formation of  
a compact complex with significant penetration inside as measured by the radial density distribution. 
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At neutral pH a higher degree of ssDNA penetration inside the dendrimer was observed. However, this 
may not constitute an advantageous phenomenon as it will prevent the release from the dendrimer and 
hence it is not useful as a gene delivery [49]. Similarly, protonated G3 and G4 PAMAM dendrimers 
with linked ssDNA were simulated using AMBER03 FF for ssDNA, GAFF for the linker and 
DREIDING FF for the dendrimer. Again, the ssDNA tended to loose helicity and wrap around the 
dendrimer with higher wrapping and DNA penetration in the case of G4 dendrimer [151]. 
Even when dsDNA (B-form) was simulated with G3 to G5 PAMAM dendrimers, a strong 
deformation of the DNA was observed [152]. Carrying MD simulations with AMBER03 FF in explicit 
water and added ions, the G5 expanded to try to cover the whole DNA while the DNA wrapped around 
the dendrimer as measured by the radius of gyration [152]. At the initial phase of the complex 
formation the dendrimer expands with increasing the contact between the dendrimer and DNA. Water 
molecules then suffer repulsion from the DNA backbone and DNA wraps on the dendrimer, forming a 
more stable complex. However, this phenomenon seems to be limited to the number of generation as it 
was shown by MD of PAMAM G7 dendrimers with siRNA, where the dendrimer behaved as a hard 
sphere with no variation in Rg after binding [99]. Higher charge ratio implies higher binding 
interaction [152]. Although the G3 is not enough to neutralize the DNA and a weak interaction occurs, 
this might be a better system as the release should be easier than in the case of a G4 or G5 [152].  
In this regard, flexible triazine dendrimers of different generations and PEI polymer were simulated 
with DsiRNA in AMBER with parm99 FF to predict their efficacy [153]. Thermodynamically, 
dendrimers were found to be more stable than PEI with G2 being the most stable complex followed by 
G4 and G3. Furthermore, the charge neutralization of 1:1 complex predicted the stability of these 
complexes in solution as it was hypothesized that PEI only interacted partially with the DsiRNA.  
The authors suggested that the non-complexed part with both positive and negative charges promoted 
inter-particle interactions leading to aggregation. Finally in vivo studies showed that the G4 was  
more stable in comparison to the G2 (less excretion) but were significantly more uptake by the 
reticulo-endothelial system [153].  
The sequence of the DNA also takes a role in the dendrimer-nucleic acid complex formation and 
thus the importance of using computational methods to predict this interaction. Using MD simulations 
with different strand composition it was found that the binding constant follows as polyG > polyC > 
polyA > polyT sequence as observed by the free energy calculations [49]. The flexibility or rigidity of 
dendrimers is another crucial point to form the polyelectrolyte complexes which was described to be 
due to the balance between the enthalpy and entropy of binding [98].  
Dendrimers are also potential systems to be used as contrast agents since they can modulate the 
pharmacokinetic profiles and organ selection. Gadolinium-based triazine dendrimers with DOTA 
chelate groups was studied as contrast agent using MD simulations with AMBER FF. In this model, 
the G3 and G5 dendrimers had 24 and 96 chelates respectively [91]. The analysis of the radial 
distribution functions showed that the chelates were exposed to the solvent and available for chelation 
of Gd ions. In fact the high peaks in the RDF suggest that there is a reduced backfolding throughout 
the simulation time.  
The multivalence of dendrimers is one of its upmost regarded advantages in which they can be design 
to perform multiple actions within the same structure. This is particularly useful in the application of 
imaging agents. In this regard, a PAMAM G5 linked to gold nanoparticles with randomly distributed 
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targeting ligand (folic acid) and imaging agent (fluorescein isothiocyanate) were simulated with  
CVFF [93]. The MD simulation was particularly useful in identifying that the fluorescent probe was at 
a significant distance from the gold metal and therefore a low quenching was expected but also that the 
folic acid was extended outwards making it available to interact. This system is interesting as it is an 
“all-in-one package”. This dendrimer system could make selective targeting of the cancer, highlight 
where it is present and then laser hyperthermia could be induced on the gold nanoparticle.  
3.5. Modeling Dendrimers as Therapeutic Agents 
Dendrimers due to their inherent similarity to biological macromolecules such as proteins can 
interact with other biomolecules and illicit biological responses [48,52]. Their high number of terminal 
groups promotes multivalent non-specific contacts that are beneficial for biological interactions. 
Furthermore, specific modifications can be introduced at the surface to promote binding. Using 
simulations on PAMAM G0 modified with guanidinium it was found that these modifications promoted 
simultaneously and cooperatively interactions with the protein surface of α-chymotrypsinogen A by 
hydrogen and cation-π interactions with the aminoacids [73]. This cooperative interaction was found to 
promote higher binding compared to a single unit. 
Dendrimers can be designed and modelled to specifically interact with the desired target. PAMAM 
G3.5 dendrimers were modelled to predict the availability of glucosamine moieties at the surface and 
their influence on biological activity. Experimentally, PAMAM G3.5 (with carboxylic groups) with  
an average of 8 surface glucosamine molecules were found to inhibit the TLR5-MD-2-LPS complex 
formation [154]. Frontier molecular orbital theory (FMOT) was applied on smaller dendrimer 
dimensions to predict the reactivity (gap difference between HOMO and LUMO) of the dendrimer 
towards subsequent addition of glucosamine monomers [90]. These studies found that solely based on 
electronic properties of the dendrimer a maximum of 12 molecules cold be coupled to the structure. 
However, upon addition of more glucosamine steric effects of hindering the terminal groups started to 
occur as evidenced by MD simulations. Together these effects accounted to an average of 4–8 as the 
most favorable energetically [90]. 
These dendrimers were subsequently docked to MD-2 protein followed by a MD simulation.  
These results showed that the dendrimer could indeed act as an antagonist of the MD-2 receptor [52] 
(see Figure 10). Analysis of the trajectory showed that the PAMAM-glucosamine’s groups could 
cooperatively bind to the hydrophilic residues at the entrance of the hydrophobic pocket [52].  
This action was enough to block the entrance of LPS into it. This effect was very important as it was 
shown to prevent the formation of the TLR4-MD-MD-2-LPS from initiating the cytokine cascade.  
The predictive knowledge of this dendrimer-glucosamine derivative to the receptor was used as the 
basis for further design of the dendrimer architecture.  
Active and non-active PETIM [155] dendrimers and Triazine-PAMAM hybrids [45] were modelled 
on the same basic principles. The modified PETIM dendrimers showed similar flexibility and the net 
surface charge was found to resemble that of the PAMAM derivative. This dendrimer was particularly 
interesting as it was a lower molecular weight compared to the original PAMAM dendrimer (easier 
synthesis and purification as well). The results from the non-active forms of this dendrimer revealed 
that the surface hydrophobicity did not contributed to the interaction with the MD-2 receptor. Similarly 
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in the case of the Triazine-PAMAM hybrids [45] it was found that the best architecture to promote 
antagonist effect was that of partially glycosylated G2 Triazine G1.5 PAMAM hybrid dendrimers.  
This dendrimer resembled the active PAMAM G3.5 glucosamine in key points such as polar surface 
area and globular shape (contrary to pure Triazine). These features facilitate the electrostatic 
interactions with the target and may justify its activity.  
Figure 10. Docking between Dendrimer glucosamine and MD-2 protein and inhibition of 
TLR4-MD-2-LPS complex formation; adapted from [52].  
cytokines
Dendrimer glucosamine-MD-2 
complex
Inhibition
LPS
TLR4-MD-2-LPS complex
 
Another interesting application of dendrimers in the biomedical field is in the area of vaccination. 
Here the core base dendrimer can be used to attachment of multiple groups depending on the type of 
immunization required. Using a database of Plasmodium falciparum epitopes, several epitopes were 
selected and attached to the dendrimer [156]. These systems were simulated using CHARMM FF and 
explicit water, and the energetics of the different structures was calculated. Although not many details 
are given, this is an interesting application of MD simulations as one could estimate the availability  
of the epitopes to the solvent. It can also be used to see the effect of adding other groups such as 
recognition groups or even fluorophores to track the intracellular path of these dendrimers.  
Even though dendrimers can be designed to specifically interact with certain proteins, while 
circulating in the plasma they will contact other proteins that can cause significant alteration of the 
pharmacokinetic profile. A common test is to study the binding affinity to albumin, the most abundant 
human plasma protein. In particular, dendrimers with their high number of terminal groups can 
promote unspecific binding and therefore bind to plasma proteins. Molecular modeling offers a 
potential test to evaluate and modulate these interactions. Using the previously described DREIDING 
FF that predicted the behavior of PAMAM at different pH, PAMAM dendrimers were simulated with 
human serum albumin to estimate the contacts between the two. It was suggested that the size and 
surface of terminal groups were crucial for this interactions. The interaction between dendrimer-HSA 
was due to electrostatic interactions between the charged groups as well as hydrogen and hydrophobic 
interactions. This interaction resulted in a backfolding conformation of PAMAM dendrimers with the 
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inner groups participating in this interaction [47]. SASA measurements were calculated to estimate 
relevant contact areas with different probe radii size. From both simulations and the NMR data it was 
suggested that PAMAM form weak complexes with HAS [47].  
4. Challenges and Perspectives 
Currently, there are over 100,000 entries in the protein databank (PDB) with experimentally 
determined structures of various biologically important molecules. In contrast there are only nine 
entries that have structures of dendrimer components reported. This is a clear indication that 
dendrimers have intrinsic properties that prevent experimental elucidation of their 3D structures and 
their interactions with components of biological systems. Computational modeling and molecular 
dynamics have been valuable tools for design and optimization of drug candidates and polymers in the 
past. Therefore, there is a growing interest in the opportunities to apply computational chemistry tools 
to study dendrimers. Molecular modeling when effectively applied on dendrimers will offer a means to 
study conformation and many features of the dynamic behavior of dendrimers on a molecular level that 
are difficult to probe experimentally. These approaches will also allow the elucidation of some of the 
key interactions of functionalized dendrimers with therapeutic molecules and biological systems such 
as proteins and lipid membranes. 
There are currently two main challenges in the modeling of dendrimers. The first is to obtain the 
initial three dimensional coordinates of the dendrimer to be used in further computational studies.  
This task can be performed manually by sketching the dendrimer with common chemical drawing 
tools with relatively ease for small generation dendrimer. However with more interesting and larger 
generation dendrimer, this approach is prone to errors. Furthermore there are no guidelines on how  
the initial structure should be assembled although it can be easily imagined that a fully stretched 
starting structure should be obtained to prevent dendrimer being stuck in a local minimum of the initial 
structures [76,105]. 
To the best of our knowledge there are only two tools that attempt to generate the starting three 
dimensional coordinates of a dendrimer of interest. Dendrimer Builder Toolkit [70] is a graphical user 
interface written in PERL that interfaces with AMBERTOOLS to build dendrimers. The other tool, 
also written in Perl, is called Silico [69], which has a module named Starmaker that generates *mol2 
file of dendrimers by building them layer by layer. Our group is developing a an alternative way of 
building dendrimers or other hyperbranched polymers using XPLOR [71] through the definition of  
a sequence of monomers and the way they are connected to each other through patch references.  
The structures generated using this approach can be converted to file formats with more general force 
fields from XPLOR topology and parameter files. We are currently working on a python GUI to 
automate the process of assembly. 
Another major issue with computationally simulating dendrimer structures is that there is no 
dedicated force field for this kind of macromolecule. This is probably due to the wide range of 
chemical bonds used to make dendrimers and that there are only few crystal structures of dendrimers. 
As a result, studies often rely on force fields developed for other macromolecules such as proteins with 
optimization of specific parameters or the use of more general force fields and these have been shown 
to be generally appropriate to predict and clarify experimental data. 
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Developing more general atom types in force fields will allow the automated generation of 
dendrimer structures, which will help to determine structure-property correlations needed to gain 
insight into their conformational behavior. Furthermore these generated dendrimer structures could be 
used in docking experiments. These types of study allow a dendrimer to be used as targets for small 
molecules or as ligand for biopolymers (protein or DNA structures). The docking solutions can be used 
in MD simulations to explore detailed intermolecular interactions. Docking studies also allow for 
selection of optimal dendrimer architecture for synthesis and further optimization. 
Despite the current challenges with the lack of dedicated force fields and tools to easily represent 
dendrimer structures, interest in dendrimers for biomedical applications remains high together with the 
increase use of computational methods to predict or validate experimental data. While most of the 
simulations have been conducted for PAMAM dendrimers, and to a lesser extent for poly(L-lysine) and 
triazine dendrimers, this is understandable by the availability of these dendrimers. It is hoped that 
sufficient MD data about other types of dendrimers will become available. Continued computation 
studies of dendrimer will yield new methods of analysis of their dynamic structural properties,  
which will be essential to their design and optimization. Finally, the expected increase in availability of 
computational power will allow the extension simulation times to probe more complex interactions, 
such as dendrimer-membrane interaction. Our hope is that the molecular modeling will become more 
widely used for dendrimers and its usefulness will compare to that which currently exists for proteins. 
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